2018 |
10/22 | 750 | 772 | 740 | 764 | +2.14% | 132,000 | 77億9822万 | -9.48% |
10/19 | 768 | 768 | 735 | 748 | -3.48% | 146,400 | 76億3491万 | -12.1% |
10/18 | 778 | 800 | 771 | 775 | -1.52% | 132,700 | 79億1050万 | -10.2% |
10/17 | 776 | 805 | 767 | 787 | +2.34% | 234,000 | 80億3298万 | -9.75% |
10/16 | 730 | 773 | 729 | 769 | +5.05% | 176,600 | 78億4925万 | -12.61% |
10/15 | 746 | 750 | 725 | 732 | -2.66% | 150,600 | 74億7159万 | -17.57% |
10/12 | 728 | 757 | 718 | 752 | +4.44% | 190,700 | 76億7573万 | -16.44% |
10/11 | 719 | 745 | 699 | 720 | -7.69% | 629,100 | 73億4911万 | -21.14% |
10/10 | 778 | 797 | 748 | 780 | +0.52% | 234,600 | 79億6153万 | -15.31% |
10/09 | 784 | 792 | 764 | 776 | -1.9% | 286,400 | 79億2070万 | -16.29% |
10/05 | 801 | 824 | 791 | 791 | -2.83% | 276,700 | 80億7381万 | -15.49% |
10/04 | 829 | 847 | 804 | 814 | -1.93% | 260,500 | 83億857万 | -13.77% |
10/03 | 857 | 865 | 791 | 830 | -3.49% | 432,400 | 84億7189万 | -13% |
10/02 | 901 | 904 | 853 | 860 | -4.34% | 409,300 | 87億7810万 | -10.23% |
10/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
10/01 | 898 | 905 | 884 | 899 | -1.53% | 184,300 | 91億7618万 | -5.77% |
09/28 | 896 | 913 | 875 | 913 | +1.78% | 260,000 | 93億1908万 | -3.69% |
09/27 | 906 | 919 | 890 | 897 | -1.86% | 286,900 | 91億5576万 | -4.57% |
09/26 | 901 | 926 | 895 | 914 | +3.16% | 296,300 | 93億2928万 | -1.93% |
09/25 | 910 | 910 | 866 | 886 | -2.74% | 485,700 | 90億4349万 | -4.01% |
09/21 | 936 | 939 | 905 | 911 | -2.04% | 560,800 | 92億9866万 | -0.65% |
09/20 | 952 | 965 | 915 | 930 | -1.9% | 821,600 | 94億9074万 | +2.42% |
09/19 | 957 | 974 | 942 | 948 | -3.56% | 489,000 | 96億7443万 | +5.57% |
09/18 | 953 | 998 | 936 | 983 | +1.87% | 497,800 | 100億3161万 | +10.57% |
09/14 | 955 | 979 | 926 | 965 | +2.12% | 405,400 | 98億4792万 | +9.91% |
09/13 | 957 | 970 | 921 | 945 | -1.66% | 629,000 | 96億4381万 | +8.87% |
09/12 | 1,037 | 1,057 | 930 | 961 | -7.77% | 1,221,200 | 98億710万 | +11.87% |
09/11 | 999 | 1,044 | 995 | 1,042 | +4.93% | 751,400 | 106億3371万 | +22.73% |
09/10 | 992 | 1,038 | 974 | 993 | +0.51% | 785,000 | 101億3366万 | +18.78% |
09/07 | 970 | 1,007 | 955 | 988 | +0.71% | 695,200 | 100億8263万 | +19.9% |
09/06 | 997 | 1,038 | 961 | 981 | -3.54% | 1,232,400 | 100億1120万 | +20.37% |
09/05 | 1,045 | 1,090 | 1,002 | 1,017 | -5.04% | 2,138,400 | 103億7858万 | +26.18% |
09/04 | 956 | 1,080 | 936 | 1,071 | +15.16% | 3,730,900 | 109億2966万 | +34.55% |
09/03 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
09/03 | 15:00 日本癌学会学術総会における発表のお知らせ |
09/03 | 923 | 954 | 904 | 930 | +1.2% | 761,000 | 94億9074万 | +18.62% |
08/31 | 971 | 993 | 906 | 919 | -9.19% | 1,557,200 | 93億7848万 | +18.28% |
08/30 | 997 | 1,035 | 964 | 1,012 | +1.2% | 1,985,500 | 103億2756万 | +30.92% |
08/29 | 1,155 | 1,167 | 992 | 1,000 | -6.1% | 7,023,000 | 102億510万 | +31.06% |
08/28 | 1,065 | 1,065 | 1,065 | 1,065 | +16.39% | 57,400 | 108億6843万 | +41.06% |
08/27 | 915 | 915 | 915 | 915 | +19.61% | 22,200 | 93億3766万 | +23.15% |
08/27 | 8:30 武田薬品工業との技術ライセンス契約締結のお知らせ |
08/24 | 759 | 778 | 744 | 765 | +2.82% | 161,400 | 78億690万 | +3.66% |
08/23 | 716 | 758 | 716 | 744 | +4.49% | 133,300 | 75億9259万 | +0.81% |
08/22 | 700 | 731 | 700 | 712 | +1.86% | 185,400 | 72億6603万 | -3.39% |
08/21 | 695 | 710 | 686 | 699 | -0.29% | 77,900 | 71億3056万 | -5.41% |
08/20 | 711 | 734 | 699 | 701 | -2.09% | 116,600 | 71億5097万 | -5.27% |
08/17 | 708 | 730 | 708 | 716 | +3.62% | 75,700 | 73億398万 | -3.63% |
08/16 | 681 | 703 | 678 | 691 | -0.14% | 93,800 | 70億4896万 | -7.25% |
08/15 | 714 | 725 | 691 | 692 | -3.08% | 122,200 | 70億5916万 | -7.36% |
08/14 | 703 | 724 | 688 | 714 | +1.28% | 142,800 | 72億8358万 | -4.93% |
08/13 | 687 | 714 | 680 | 705 | -0.7% | 155,800 | 71億9177万 | -6.5% |
08/10 | 16:30 (数値データ訂正)「平成30年12月期第2四半期決算短信〔日本基準〕(連結)」におけるXBRLデータの一部訂正について |
08/10 | 15:00 第2四半期(累計)連結業績予想と実績値との差異及び平成30年12月期通期連結業績予想の修正に関するお知らせ |
08/10 | 15:00 平成30年12月期第2四半期決算短信〔日本基準〕(連結) |
08/10 | 717 | 730 | 703 | 710 | -3.92% | 74,500 | 72億4278万 | -6.21% |
08/09 | 711 | 744 | 711 | 739 | +4.53% | 150,000 | 75億3861万 | -2.51% |
08/08 | 690 | 711 | 684 | 707 | +0.57% | 108,300 | 72億1217万 | -6.85% |
08/07 | 716 | 721 | 691 | 703 | -1.68% | 127,600 | 71億7137万 | -7.74% |
08/06 | 733 | 738 | 715 | 715 | -3.51% | 150,400 | 72億9378万 | -6.54% |
08/03 | 767 | 767 | 736 | 741 | -3.39% | 139,200 | 75億5901万 | -3.64% |
08/02 | 769 | 782 | 765 | 767 | -0.52% | 76,000 | 78億2424万 | -0.65% |
08/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
08/01 | 770 | 772 | 753 | 771 | +0.65% | 81,200 | 78億6504万 | -0.39% |
07/31 | 763 | 767 | 746 | 766 | +0.13% | 88,300 | 78億1404万 | -1.16% |
07/30 | 791 | 791 | 758 | 765 | -4.14% | 182,500 | 78億384万 | -1.42% |
07/27 | 794 | 803 | 774 | 798 | +2.05% | 105,000 | 81億4047万 | +2.57% |
07/26 | 793 | 811 | 760 | 782 | -1.64% | 280,100 | 79億7726万 | +0.13% |
07/25 | 775 | 818 | 766 | 795 | +2.98% | 194,000 | 81億987万 | +1.4% |
07/24 | 775 | 793 | 754 | 772 | +0.13% | 133,400 | 78億7524万 | -1.78% |
07/23 | 750 | 776 | 741 | 771 | +1.05% | 130,200 | 78億6504万 | -2.41% |
07/20 | 745 | 770 | 738 | 763 | +3.39% | 167,900 | 77億8343万 | -4.03% |
07/19 | 783 | 787 | 735 | 738 | -3.15% | 255,400 | 75億2841万 | -7.87% |
07/18 | 15:00 アルツハイマー治療貼付剤MRX-7MLL非臨床試験開始のお知らせ |
07/18 | 725 | 766 | 723 | 762 | +5.54% | 223,800 | 77億7323万 | -5.69% |
07/17 | 765 | 766 | 718 | 722 | -6.23% | 338,600 | 73億6519万 | -11.41% |
07/13 | 776 | 789 | 764 | 770 | +1.18% | 137,200 | 78億5484万 | -6.33% |
07/12 | 760 | 774 | 754 | 761 | +0.53% | 109,900 | 77億6303万 | -8.09% |
07/11 | 777 | 802 | 749 | 757 | -1.69% | 227,200 | 77億2223万 | -9.77% |
07/10 | 802 | 807 | 769 | 770 | -4.7% | 210,900 | 78億5484万 | -8.77% |
07/09 | 778 | 809 | 766 | 808 | +4.66% | 249,100 | 82億4248万 | -4.83% |
07/06 | 747 | 773 | 735 | 772 | +5.46% | 196,200 | 78億7524万 | -9.39% |
07/05 | 772 | 788 | 729 | 732 | -5.79% | 255,100 | 74億6720万 | -14.69% |
07/04 | 759 | 786 | 751 | 777 | +1.57% | 156,600 | 79億2625万 | -10.38% |
07/03 | 784 | 800 | 755 | 765 | -3.65% | 306,800 | 78億384万 | -12.27% |
07/02 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
07/02 | 802 | 815 | 791 | 794 | -1.73% | 101,600 | 80億9967万 | -9.67% |
06/29 | 802 | 830 | 794 | 808 | +0.62% | 124,800 | 82億4248万 | -8.8% |
06/28 | 810 | 823 | 788 | 803 | -2.07% | 209,500 | 81億9148万 | -10.08% |
06/27 | 801 | 821 | 795 | 820 | +1.23% | 147,100 | 83億6490万 | -9.09% |
06/26 | 775 | 811 | 767 | 810 | +3.98% | 301,100 | 82億6289万 | -11.09% |
06/25 | 830 | 845 | 774 | 779 | -5.8% | 371,700 | 79億4665万 | -15.42% |
06/22 | 843 | 850 | 820 | 827 | -4.06% | 145,900 | 84億3630万 | -11.27% |
06/21 | 870 | 888 | 850 | 862 | 0% | 151,900 | 87億3326万 | -8.59% |
06/20 | 825 | 868 | 800 | 862 | +3.23% | 313,500 | 87億3326万 | -9.36% |
06/19 | 876 | 881 | 814 | 835 | -5.11% | 429,300 | 84億5971万 | -12.84% |
06/18 | 904 | 904 | 857 | 880 | -3.19% | 327,300 | 89億1563万 | -9% |
06/15 | 902 | 923 | 902 | 909 | +0.11% | 120,300 | 92億944万 | -6.67% |
06/14 | 906 | 920 | 904 | 908 | -0.44% | 107,100 | 91億9931万 | -7.35% |
06/13 | 920 | 921 | 901 | 912 | -0.98% | 194,900 | 92億3983万 | -7.69% |
06/12 | 906 | 921 | 898 | 921 | +1.66% | 240,600 | 93億3101万 | -7.53% |
06/11 | 924 | 942 | 906 | 906 | -2.79% | 340,600 | 91億7904万 | -9.85% |
06/08 | 1,033 | 1,035 | 928 | 932 | -9.78% | 2,125,200 | 94億4246万 | -8.09% |
06/07 | 1,000 | 1,033 | 977 | 1,033 | +16.99% | 602,900 | 104億6573万 | +1.08% |
06/06 | 15:00 MRX-5LBTの生物学的同等性を示す検証的臨床試験結果のお知らせ |
06/06 | 879 | 899 | 863 | 883 | +0.46% | 167,000 | 89億4602万 | -13.85% |
06/05 | 885 | 896 | 860 | 879 | -2.33% | 335,400 | 89億550万 | -15.07% |
06/04 | 926 | 928 | 885 | 900 | -2.6% | 254,900 | 91億1826万 | -14.04% |
06/01 | 15:00 第三者割当による第13回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
06/01 | 927 | 952 | 917 | 924 | -1.7% | 122,500 | 93億6141万 | -12.67% |
05/31 | 926 | 941 | 922 | 940 | +2.4% | 95,900 | 95億2351万 | -11.82% |
05/30 | 900 | 941 | 897 | 918 | -0.33% | 269,700 | 93億62万 | -14.6% |